Banque de Luxembourg’s Edwards Lifesciences EW Stock Holding History

Banque de Luxembourg’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,824	Closed	-$136K	–	91
2024 Q4	$136K	Buy	+1,824	New	+$128K	0.07%	60

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Banque de Luxembourg's EW Position: Q1 2025 in Review

Banque de Luxembourg sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 1,824 shares — an estimated $136K sold.

Banque de Luxembourg first reported a position in EW in Q4 2024 and held it in 1 quarter. The position peaked at $136K in Q4 2024. 1,207 funds tracked by Wall St. Rank hold EW as of Q1 2025.

Banque de Luxembourg reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
Banque de Luxembourg sold 1,824 Edwards Lifesciences shares in Q1 2025, an estimated $136K.
Banque de Luxembourg first reported a position in Edwards Lifesciences in Q4 2024 and held it in 1 quarter.
Banque de Luxembourg's Edwards Lifesciences position peaked at $136K in Q4 2024.
1,207 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Banque de Luxembourg's 13F filing for Q1 2025, filed 14 May 2025.